Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

Overview of attention for article published in BMC Cancer, February 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 26 followers.

#fridayreads: new insights on @liver_cancer Want to know how Gal-3C can be used as anti-cancer therapy? This study developed a novel fusion protein (PK5-RL-Gal-3C) and showed how it's beneficial effect in hepatocellular carcinoma https://t.co/FA7oALBZ

24 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.